Skip to content

Search for:

Home
About
News
Events
Community
Members
Donate
- ISMRM Research & Education Fund »
- SMRT Scholarship Fund »
Education
Career Center
Log In

Quiz: Kidneys & Bladder 2

Home/Online Education Program/Body GU Videos/Quiz: Kidneys & Bladder 2

Quiz: Kidneys & Bladder 2admin2020-03-23T15:09:40-07:00

Kidneys & Bladder Part 2: Solid Renal Lesions
by Ivan Pedrosa

Objectives: This course is a comprehensive review of the most important aspects of Genito-Urinary MRI, covering multiple organs and diagnoses. The knowledge required for general competence in interpreting GU MRI exams is delivered in 15 lectures by international experts on each topic.
1. Which are the indications for renal MRI? Select all that apply.*
- Modality of choice for radiation-free workup of hematuria
- Contra-indications for iodinated contrast
- Radiation protection in paediatric population
- Characterization of renal masses when CT and US are inconclusive
- Differentiation of cystic versus solid lesions in pregnant patients
- Assessment of Bosniak II or IIF cysts on CT scan.
Jump to the relevant part of the video for question 1:
2. What is the current role of MRI of renal masses?*
- To distinguish benign from malignant neoplasms
- To replace ultrasound as the modality of choice for assessment of incidental renal lesions
- To predict subtypes of renal masses
- To confirm presence of suspected renal masses and detect internal enhancement
- None of the above
Jump to the relevant part of the video for question 2:
3. Which statement(s) is(are) CORRECT regarding fat containing renal lesions? Select all that apply.*
- Loss of signal on GRE T1-weighted images (T1WI) is diagnostic for angiomyolipoma (AML).
- Signal intensity (SI) index on GRE T1WI can be used to differentiate AML from clear cell RCC (ccRCC).
- RCC can be differentiated from minimal fat AML using T2 SI ratio.
- Combination of T2 SI ratio and Arterial-Delayed Enhancement Ratio increases accuracy of differentiating AML with minimal fat from papillary RCC (pRCC)
- Presence of intralesional fat is 100% accurate in differentiating pRCC from ccRCC.
- Necrosis in a fat-containing lesion excludes AML from differential diagnosis.
Jump to the relevant part of the video for question 3:
4. Which statement(s) is(are) CORRECT regarding renal mass phenotypes? Select all that apply.*
- Hemorrhagic cyst + enhancing papillary projections = Papillary RCC (pRCC)
- Necrosis + septae and enhancing nodules = low grade clear cell RCC (ccRCC)
- Hyper-intense on T2WI + avid enhancement = ccRCC or Oncocytoma
- Hypo-intense on T2WI + low grade enhancement = pRCC
- Hypo-intense on T2WI + Segmental enhancement inversion = Oncocytoma
Jump to the relevant part of the video for question 4:
5. What information should be included in the radiology report for pre-surgical evaluation of a renal mass? Select all that apply.*
- Lesion subtype, if possible
- Arterial & venous anatomy
- Side, Location and size of the lesion
- Relationship of lesion margins compared to renal capsule and renal pelvis fat
- Number and location of abnormal lymph nodes
- Presence and extent of venous thrombus in renal veins and IVC
- Presence of adrenal or distant metastases
Jump to the relevant part of the video for question 5:

International Society for Magnetic Resonance in Medicine
2300 Clayton Road, Suite 620 | Concord, CA, 94520 USA

Phone: +1.510.841.1899
Fax: +1.510.841.2340
e-mail: info@ismrm.org

© 2020 ISMRM, All Rights Reserved

About Us

Contact
About the ISMRM
Privacy Policy

Community

Facebook
Twitter
YouTube
LinkedIn
Instagram
Links of Interest
Information for Patients

Latest from @ISMRM on

Ready for the meeting? Watch a discussion with ISMRM President, Larry Wald, Ph.D. and SMRT President, Shawna Farquh… twitter.com/i/web/status/1…
5 months ago
So many great talks! I just can't stop watching... @ISMRM @SMRT_ISMRM #ismrm20 #bestvirtualISMRMever pic.twitter.com/kVUMOoIWuN
5 months ago

⨯

Search ISMRM.org:

⨯

Translate ISMRM: